Aidence, founded in 2015 and based in Amsterdam, Netherlands, specializes in AI-powered clinical applications aimed at enhancing lung cancer diagnostics. Their flagship product, Veye Lung Nodules, is a CE-certified solution that automates lung nodule detection and quantification on chest CT scans, integrating seamlessly into radiology workflows. Their flagship product, Veye Lung Nodules, is a CE-certified solution that automates lung nodule detection and quantification on chest CT scans, integrating seamlessly into radiology workflows.<\/p>\n\n\n\n
In January 2022, Aidence was acquired by RadNet, a leading U.S. provider of diagnostic imaging services. This acquisition has enabled Aidence to expand its AI solutions and further its mission to improve patient outcomes through advanced technology. This acquisition has enabled Aidence to expand its AI solutions and further its mission to improve patient outcomes through advanced technology.<\/p>\n\n\n\n
Aidence is located at Westblaak 130, 3012 KM, Rotterdam, The Netherlands. For inquiries, they can be reached at +31 108 411 749 or via email at [email For inquiries, they can be reached at +31 108 411 749 or via email at [email protected].<\/p>\n\n\n\n